

Management of psoriatic arthritis has advanced substantially in recent years, with emerging targeted therapies and disease-specific studies redefining patient outcomes. The high burden of comorbidities associated with the disease—the theme of World Psoriasis day 2025—alongside limited understanding of disease pathogenesis, highlights the continued need for optimised care and innovative therapies.
Rheumatology
|11th Mar, 2026
|The New England Journal of Medicine
Rheumatology
|11th Mar, 2026
|The New England Journal of Medicine
Rheumatology
|11th Mar, 2026
|The Lancet
Rheumatology
|11th Mar, 2026
|The Lancet
Rheumatology
|11th Mar, 2026
|The Lancet
Rheumatology
|11th Mar, 2026
|The Lancet
Rheumatology
|11th Mar, 2026
|The Lancet